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Sigma σ1 and σ2 receptors are targets of cocaine. Despite sharing a similar name, the
two receptors are structurally unrelated and their physiological role is unknown. Cocaine
increases the level of dopamine, a key neurotransmitter in CNS motor control and reward
areas. While the drug also affects dopaminergic signaling by allosteric modulations
exerted by σ1R interacting with dopamine D1 and D2 receptors, the potential regulation
of dopaminergic transmission by σ2R is also unknown. We here demonstrate that σ2R
may form heteroreceptor complexes with D1 but not with D2 receptors. Remarkably
σ1, σ2, and D1 receptors may form heterotrimers with particular signaling properties.
Determination of cAMP levels, MAP kinase activation and label-free assays demonstrate
allosteric interactions within the trimer. Importantly, the presence of σ2R induces bias
in signal transduction as σ2R ligands increase cAMP signaling whereas reduce MAP
kinase activation. These effects, which are opposite to those exerted via σ1R, suggest
that the D1 receptor-mediated signaling depends on the degree of trimer formation
and the differential balance of sigma receptor and heteroreceptor expression in acute
versus chronic cocaine consumption. Although the physiological role is unknown, the
heteroreceptor complex formed by σ1, σ2, and D1 receptors arise as relevant to convey
the cocaine actions on motor control and reward circuits and as a key factor in
acquisition of the addictive habit.
Keywords: acute, addiction, cAMP, chronic, dopamine D1 and D2 receptors, ERK1/2 phosphorylation, label-free,
signaling
INTRODUCTION
In advanced societies cocaine addiction is an important health and socio-economic problem.
Cocaine use begins recreationally and the seeking behavior is based on a feeling of general well-
being. Drug addiction is the result of plastic changes in areas of the brain that have dopamine as
the main neurotransmitter, particularly in the ventral tegmental area (VTA) (see Lüscher, 2013 and
references therein). The main consequence of cocaine consumption in the central nervous system
(CNS) is an increase in interneuronal dopamine levels, which is not limited to VTA but extends
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to other structures, such as the basal ganglia (Wise, 1984;
Bradberry, 2008). It was thought that the inhibition of dopamine
transporters was at the root of all the effects caused by this
drug of abuse. However, there is strong evidence showing that
cocaine exerts effects by a direct interaction with sigma receptors.
Two different sigma receptors have been identified that are
functionally and structurally unrelated. Although endogenous
ligands are not known and the physiological function of
sigma receptors is unclear, these receptors share the ability to
bind cocaine. On the one hand, sigma-1 receptor (σ1R) is a
chaperone that spans once the membrane bilayer and whose
recently reported structure consists of a homotrimer (Schmidt
et al., 2016). On the other hand, sigma-2 receptor (σ2R) was
identified as a member of the family of membrane-associated
progesterone receptors; apart from σ2R (PGRMC1), three other
human members are identified: PGRMC2, neuferricin, and
neudesin. They are haem proteins displaying a cytochrome
b5-fold domain. While σ2R dimerization affects proliferation
and chemoresistance in tumor/metastasis in vitro models and
xenograft- based tumor/metastasis models, the mode of action in
the periphery and the CNS are virtually unknown (Kabe et al.,
2016; reviewed in Cahill, 2017). The interaction of σ1R with
dopamine receptors and the relevant role that σ1R exerts on
the modulation of dopaminergic signaling by cocaine has been
reported. In contrast, no study has been undertaken to know
whether the binding of cocaine to σ2R results in dopaminergic
regulation.
The role of σ1R as relevant target of cocaine was suspected
due to the moderate affinity of drug binding to the receptor
(Matsumoto et al., 2003; Hayashi and Su, 2005). Therefore,
it seems that the “physiologically” relevant concentrations of
cocaine can both inhibit the uptake of dopamine and activate
σ1R. σ1R-cocaine interaction intervenes in the triggering of
locomotor and convulsive actions of the drug (Menkel et al.,
1991; Matsumoto et al., 2001a,b, 2002; Barr et al., 2015). In
addition, synthetic drugs that act as σ1R agonists and antagonists,
respectively, potentiate (Matsumoto et al., 2002, 2003) and
reduce (Matsumoto et al., 2004) cocaine actions. More recent
studies have identified in both heterologous expression systems
and natural sources an interaction between σ1R and dopamine
receptors (Navarro et al., 2010; Moreno et al., 2014; Borroto-
Escuela et al., 2017). Accordingly, it has been suggested that
dual antagonism of σ1R and inhibition of the dopamine DAT
transporter can effectively block cocaine self-administration
(Katz et al., 2016). Matsumoto et al. (2007) reported that
treatment with synthetic drugs that act on σ2R attenuates
cocaine-derived behavior in mice. Although the selectivity of
the compounds was poor, 1 year later, Mésangeau et al. (2008)
designed an approach for converting selective σ1R ligands into
σ2R selective ligands that, importantly, showed anti-cocaine
activity. Furthermore, it has been observed that treatment with
σ2R antagonists counteract locomotor stimulation induced by
cocaine in mice (Lever et al., 2014; Guo and Zhen, 2015).
An important physiological consequence of cocaine ingestion
is an increase in motor activity, which is controlled by basal-
ganglia brain circuits. Motor control is exerted by the direct
and indirect pathways of the basal ganglia and associated nuclei.
Of the five types of dopamine receptors, the D1 (D1R) is enriched
in the direct pathway, while the D2 (D2R) is enriched in the
indirect route. The balance of the dopaminergic input in the
two circuits results in fine-tuning motor control. The locomotor
hyperactivity resulting from cocaine use probably reflects a lack
of balance in these two routes. The objective of this work
was to investigate how the binding of cocaine to σ2R affects
dopaminergic signaling mediated by D1R and/or D2R. We first
investigated whether σ2R interacts with D1R or with D2R and,
subsequently, we observed how cocaine could affect in a σ1R-
independent but σ2R-dependent fashion the signal transduction
triggered by agonist activation of D1R but not of D2R.
RESULTS
σ2R May Form Complexes with
Dopamine D1 But Not with Dopamine
D2 Receptors
Two different sigma receptors have been described, the non-
opioid receptor, σ1R, and the PGRMC-1 protein, also known
as σ2. Despite the endogenous ligands are not known, the two
sigma receptors may bind cocaine. While recent studies have
demonstrated that σ1R is involved in cocaine modulation of
dopamine receptor function, a similar study on σ2R-mediated
modulation of dopaminergic signaling is lacking. We first
evaluated in a heterologous expression system whether σ2R may
colocalize with dopamine receptors at the plasma membrane.
Immunocytochemistry assays were undertaken in HEK-293T
cells expressing σ2R fused to Rluc and either dopamine D1R fused
to YFP or dopamine D2R fused to YFP. The σ2R expression
was identified by a specific antibody against Rluc protein
and a secondary Cy3 antibody, while dopamine receptor-YFP
expression was identified by its own fluorescence. D1R (green)
was detectable at the plasma membrane level while σ2R (red)
was expressed both in intracellular structures and at the plasma
membrane, where it colocalized (yellow) with D1R (Figure 1A,
left images). When a similar experiment was developed with
D2R, similar results were obtained indicating that D2R and σ2R
colocalize at the cell surface (Figure 1A, right images). When the
immunocytochemical assays were performed in cells pretreated
with 30 µM cocaine for 30 min, the level of colocalization
between σ2R and D1R or D2R was similar, indicating that cocaine
pretreatment did affect neither cell surface expression of σ2R,
D1R or D2R nor receptor colocalization. Next, we determined
whether σ2R may form heteromer complexes with dopamine
D1 or D2 receptors. For this purpose, we took advantage of
energy transfer assays and in situ proximity ligation assay (PLA),
which allows the identification of close proximity between two
proteins (<17 nm) (Borroto-Escuela et al., 2011; Trifilieff et al.,
2011). For PLA, HEK-293T cells expressing σ2R and either
D1R or D2R were treated with specific primary antibodies
against σ2R and against each of the dopamine receptors.
Interestingly, the red punctuated signal around Hoechst-stained
nuclei was much higher for D1R and σ2R than for D2R and
σ2R (82 versus 27% of labeled cells) (Figure 1B). Finally,
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FIGURE 1 | Expression of σ2R-containing heteromer complexes in a heterologous expression system. To determine colocalization between σ2R and dopamine D1
or D2 receptors, immunocytochemistry assays were performed in HEK-293T pretreated or not with 30 µM cocaine for 30 min. HEK-293T cells expressing σ2R-Rluc
(1 µg cDNA), D1R-YFP (1 µg cDNA), D2R-YFP (1 µg cDNA), σ2R-Rluc (1 µg cDNA) and D1R-YFP (1 µg cDNA) or σ2R-Rluc (1 µg cDNA) and D2R-YFP (1 µg cDNA)
were used. Dopamine receptors were detected by YFP fluorescence (green) and σ2R was detected by a specific antibody against Rluc (1/100, Millipore, Temecula,
CA, United States) followed by a Cy3-conjugated secondary antibody (1/200, Jackson Immunoresearch Laboratories, West Grove, PA, United States) (red).
Colocalization is shown in yellow (A). Scale bar 5 µm. In situ proximity ligation assay (PLA) was developed in HEK-293T cells expressing D1R (1 µg cDNA) or D2R
(1 µg cDNA) and σ2R (1 µg cDNA) by the use of specific primary antibodies (1/100 dilution) against D1R, D2R and/or σ2R. Nuclei were stained with Hoechst (1/100).
Confocal microscopy images (four superimposed sections) were obtained showing D1R-σ2R or D2R-σ2R complexes as red spots (B). Scale bar 5 µm.
Quantification of the PLA provides in the Y-axis the ratio r (number of red spots/cell containing spots) and, above each bar, the percentage of positive cells versus the
total number of cells (blue nucleus). Data are the mean ± SEM of four different fields in five independent preparations. One way ANOVA and Dunnett’s post hoc test
showed statistically significant differences (∗∗∗p < 0.001).
we developed bioluminescence energy transfer assays in HEK-
293T cells transfected with cDNAs for D1R-Rluc or D2R-Rluc
and increasing amounts of cDNA for σ2R-YFP. Interestingly, a
saturable BRET curve was obtained (BRETmax 50 ± 3, BRET50
190 ± 40) (Figure 2A) indicating a specific interaction between
D1R-σ2R; in contrast, a linear signal was obtained between D2R-
σ2R (Figure 2B) suggesting a lack of interaction between them.
When the same experiments were undertaken in cells treated
with cocaine, similar results were obtained for the D1R-Rluc/σ2R-
YFP donor/acceptor pair (BRETmax 82± 10, BRET50 680± 200),
indicating that cocaine did not significantly affect the interaction
(Figure 2B).
Dopamine D1R, σ1R, and σ2R May Form
Heterotrimeric Complexes
Dopamine D1 and σ1 receptors may form heteromeric complexes
in HEK-293T cells (Navarro et al., 2010). To confirm whether
in our experimental conditions D1R-Rluc may act as a donor
of σ1R-YFP, BRET experiments undertaken in cotransfected
HEK-293T cells provided a saturable curve thus indicating
the interaction between σ1R and D1R (Figure 2C). We then
hypothesized that σ1R and σ2R could be interacting together.
Accordingly, BRET assays were performed in HEK-293T cells
expressing a constant amount of σ1R-Rluc and increasing
amounts of σ2R-YFP. The unspecific linear signal obtained
(Figure 2D) suggested that no interaction was occurring between
the two sigma receptors. We then performed assays to investigate
whether σ1R and σ2R competed for the binding to D1R.
BRET experiments were then developed in HEK-293T cells
expressing a constant amount of σ1R-Rluc and D1-YFP and
increasing amounts of non-fused σ2R. The results indicated
that σ2R was not able to compete with σ1R for heteromer
formation since the energy transfer between donor and acceptor
was not altered (Figure 2E). When a similar experiment was
performed expressing a constant amount of D1-Rluc and of
σ2R-YFP and increasing amounts of non-fused σ1R, the results
indicated that low expression levels of σ1R increased BRET
signals; however, higher expression levels σ1R were able to
displace σ2R out of the heteromer, as reflected by a significant
decrease in BRET signal (Figure 2F). This result could reflect
the formation of D1R-σ1R-σ2R heterotrimer complexes, where
the interaction of σ1R to the σ2R-D1R complex could create a
structural change in turn leading to increasing the energy transfer
between Rluc and YFP. To confirm this possibility, sequential
resonance energy transfer (SRET) assays, which permits detection
of trimers (Carriba et al., 2008), were developed in HEK-293T
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FIGURE 2 | Identification of D1R-σ1R-σ2R heteromers in a heterologous expression system. Bioluminescence energy transfer (BRET) was developed in HEK-293T
cells expressing (i) a constant amount of D1R-Rluc (0.3 µg cDNA) (A) or D2R-Rluc (0.25 µg cDNA) (B) and increasing amounts of σ2R-YFP (0.5–4 µg cDNA), or (ii) a
constant amount of D1R-Rluc (0.3 µg cDNA) and increasing amounts (0.5–4.5 µg cDNA) of σ1R-YFP (C) or (iii) a constant amount of σ1R-Rluc (0.1 µg cDNA) and
increasing amounts of σ2R-YFP (1–6 µg cDNA) (D). Cells were treated (red line) or not (black line) with 30 µM cocaine for 30 min. BRET is expressed as milli BRET
units (mBU) and is given as the mean ± SEM of seven different experiments. Competition experiments were developed in HEK-293T cells expressing a constant
amount of σ1R-Rluc (0.1 µg cDNA) and D1-YFP (1.5 µg cDNA) and increasing amounts of unfused σ2R (0–5 µg cDNA) (E) or a constant amount of D1-Rluc
(0.05 µg cDNA) and σ2R-YFP (0.3 µg cDNA) and increasing amounts of unfused σ1R (0–5 µg cDNA) (F). Transfer of energy was expressed as milli BRET units
(mBU) and results are given as the mean ± SEM of 10 different experiments. One way ANOVA and Dunnett’s post hoc test showed statistically significant differences
(∗p < 0.05, ∗∗p < 0.01). (G) Sequential resonance energy transfer (SRET) assay developed in HEK-293T cells transfected with constant amounts of σ1R-Rluc
(0.2 µg cDNA) and D1R-YFP (1.5 µg cDNA) and increasing amounts of σ2R-RFP (0.5–4 µg cDNA). A negative control was performed using cDNA for the
cannabinoid CB1 receptor (fused to RFP) instead of cDNA for σ2R-RFP. SRET is expressed as milli SRET units (mSU) and are given as the mean ± SEM of 6
different experiments. (H) Schematic representation of SRET.
cells expressing a constant amount of σ1R-Rluc and of D1R-
YFP and increasing amounts of σ2R-Cherry. The saturable
SRET curve indicates that formation of σ1R-D1R-σ2R heteromer
complexes was occurring (Figures 2G,H). The negative control
was performed by substituting σ2R-RFP by the cannabinoid CB1
receptor fused to RFP thus confirming the specificity of the triple
σ1R-D1R-σ2R interaction (Figure 2G).
σ2R Activation Blocks Dopamine D1R
Signaling
Our next aim was to characterize the functionality of the σ1R-
D1R-σ2R heterotrimer structure in HEK-293T cells treated with
cocaine. It should be noted that σ1R (Navarro et al., 2010) and σ2R
(Johannessen et al., 2011) are endogenously expressed in HEK-
293T cells; consequently, we used a siRNA approach to silence
σ1R or σ2R expression thus impeding heterotrimer formation.
When HEK-293T cells were transfected with D1R and siRNA for
σ1R, SKF-81297-induced a significant increase in cAMP levels,
that was inhibited by pretreatment with cocaine or with the σ2R
agonist, PB-28, indicating that cocaine decreases D1R-mediated
cAMP signaling function through its binding to σ2R (Figure 3A).
When HEK-293T cells were transfected with D1R and siRNA for
σ2R, the results indicated that cocaine pretreatment potentiated
agonist-induced cAMP levels, which was evidence of cocaine
action upon binding to the σ1R (Figure 3B). The next set of
results is consistent with a reciprocal modulation of signaling
mediated by cocaine binding to σ2R and σ1R; while cocaine
via σ1R positively modulates cAMP levels, it inhibits cAMP
signaling via σ2R. Accordingly, no effect of cocaine was observed
in HEK-293T expressing D1R and the two endogenous sigma
receptors (Figure 3C). The lack of modulation exerted by cocaine
upon simultaneous binding to both σ1R and σ2R likely reflects
a balance which would, in a physiological set-up, depend on the
relative expression of the two sigma receptors. In fact, when HEK-
293T cells were transfected with D1R and both siRNA for σ1R
and σ2R, cocaine or the specific σ2R agonist, PB-28, had no effect,
indicating that cocaine modulation over D1R depends on σ1R and
σ2R expression (Figure 3D).
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FIGURE 3 | σ2R modulation of D1 receptor-mediated signaling in a heterologous expression system. cAMP determination experiments were developed in HEK-293T
cells expressing D1R (A–D) or D2R (E–H) in the absence (C,G) or presence of 3 µg siRNA for σ1R (A,E), 3 µg siRNA for σ2R (B,F) or both (D,H). Cells were
pretreated with 30 µM cocaine for 30 min, 300 nM PB-28 or vehicle 15 min prior to receptor activation using 200 nM SKF-81297 or 500 nM sumanirole. In cells
expressing D2R 0.5 µM forskolin was used to induce increases in cAMP levels. Basal [cAMP] is considered 100% in cells expressing D1R, whereas
forskolin-induced [cAMP] is considered 100% in cells expressing D2R. Values are the mean ± SEM of 12–15 different experiments. One way ANOVA followed by a
Dunnett’s multiple comparison post hoc test showed a significant effect of treatments versus control (∗∗∗p < 0.001), a significant effect of treatments versus
SKF-81297 (#p < 0.05, ##p < 0.01, and ###p < 0.001) and a significant effect of treatments versus sumanirole (&&p < 0.01 and &&&p < 0.001).
We next investigated whether cocaine binding to σ2R
receptors could still modulate D2R-mediated signaling.
HEK-293T cells transfected with cDNAs for D2R and siRNA
for σ1R, responded to the selective-D2R agonist, sumanirole. In
these cells the Gi-mediated decrease of forskolin-induced cAMP
accumulation due to Gi coupling was not affected by cocaine
pretreatment (Figure 3E). These results agree with the lack of
interaction between σ2R and dopamine D2R (see Figure 2B). As
a control, we confirmed that when the σ1R-cocaine modulation
over D2R was assayed, i.e., silencing σ2R expression, cocaine
was able to block the sumanirole-induced effect (Figure 3F).
These results agree with those in Navarro et al. (2013) in the
sense that they reflect the consequence of a physical interaction
between σ1R and D2R receptors. In agreement with this
hypothesis, HEK-293T cells expressing D2R and endogenous
sigma receptors behaved as cells in which the σ2R was silenced
(Figure 3G). As a further control, HEK-293T cells treated with
siRNAs to silence both sigma receptors showed no modulation
by cocaine over D2R-mediated signaling (Figure 3H), thus
reinforcing the idea that cocaine effect over D2R depends on σ1R
expression.
σ2R Activation Potentiates Dopamine
D1R MAP Kinase Phosphorylation
To further understand the cocaine effect over D1R function, MAP
kinase signaling was evaluated in HEK-293T cells transfected
with cDNAs for D1R and siRNA for either σ1R or σ2R. In
cells expressing D1R with silenced σ1R, i.e., expressing D1R
and σ2R (Figure 4A), cocaine pretreatment increased agonist
(SFK-81297)-induced ERK1/2 phosphorylation, while in cells
with silenced σ2R, i.e., expressing D1R and σ1R (Figure 4B),
cocaine decreased agonist-induced ERK1/2 phosphorylation.
These results are evidence of potentiation by cocaine-σ2R of
MAP kinase signaling, and potentiation by cocaine-σ1R of Gs-
protein dependent signaling. In cells expressing D1R and the two
sigma receptors, no effect of cocaine pretreatment on pERK1/2
levels was observed, in agreement with the above-described
balance resulting from reciprocal sigma-receptor-mediated
cocaine effects (Figure 4C). As a further control, cocaine
did not alter the SKF-81297-induced ERK1/2 phosphorylation
in HEK-293T cells expressing D1R and with silenced sigma
receptors (Figure 4D). A similar experimental design was used
to undertake dynamic mass redistribution (DMR) assays. DMR
is a label-free technique useful to investigate the activation of
G-protein coupled receptors (Grundmann and Kostenis, 2015;
Medrano et al., 2017). On the one hand, in cells expressing
D1R and σ2R, cocaine blocked SKF-81297-induced increase in
the DMR signal in a similar way as the selective σ2R ligand,
PB-28, did (Figure 4E). On the other hand, the SKF-81297
effect was potentiated by cocaine pretreatment in cells expressing
D1R and σ1R (Figure 4F). Once more, cocaine modulation on
D1R-agonist-induced effects was not found in cells expressing
D1R and both sigma receptors (Figure 4G). As DMR in cells
expressing D1R mainly reflects Gs-coupling (Kebig et al., 2009;
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FIGURE 4 | Cocaine effects on D1R-mediated signaling. MAP kinase activation was determined in HEK-293T cells transfected with 0.75 µg cDNA for D1R in the
absence (C) or presence of 3 µg siRNA for σ1R (A), 3 µg siRNA for σ2R (B) or both (D). The culture medium was replaced by non-supplemented DMEM and 2 h
later cells were treated for 30 min with 30 µM cocaine, 300 nM PB-28 or vehicle followed by a 200 nM SKF-81297 stimulation (7 min). The basal level of pERK1/2 is
considered 100%. Values are the mean ± SEM of 10–12 different experiments. One way ANOVA followed by a Dunnett’s multiple comparison post hoc test showed
a significant effect of treatments versus control (∗p < 0.05, ∗∗∗p < 0.01) and a significant effect of treatments versus SKF-81297 (#p < 0.05, ##p < 0.01, and
###p < 0.001). Real-time DMR signal 60 min recordings in HEK-293T cells transfected with 0.75 µg cDNA for D1R in the absence (G) or presence of 3 µg siRNA for
σ1R (E), 3 µg siRNA for σ2R (F) or both (H) that were treated with 30 µM cocaine (red), 300 nM PB-28 (dark blue) or vehicle (green) for 30 min previous to 200 nM
SKF-81297 stimulation.
Schröder et al., 2009; Hamamoto et al., 2015), these results
are similar to those obtained in cAMP read-outs. Another
control was performed to show that pretreatment with the σ2R
selective agonist, PB-28, did not result in any signal modulation
in cells expressing D1R but silenced σ1R and σ2R expression
(Figure 4H).
σ2R Activation Blocks Dopamine
D1R-Mediated Signaling in Primary
Cultures of Striatal Neurons
A proximity ligation assay (PLA) was used to determine
in primary cultures of striatal neurons whether D1R-σ2R
complex expression was affected by cocaine pretreatment.
Consequently, specific antibodies against D1R and σ2R were
used in neurons treated or not with cocaine for 30 min
(Figure 5A). 32% of cells showed punctuated staining (with
2.2 red spots/cell containing spots) surrounding Hoechst-stained
nuclei (Figure 5B). These results indicate the occurrence of D1-σ2
heteroreceptor complexes in striatal primary cultures of neurons.
A control done in the absence of primary antibodies led to
18% of labeled cells (with 1.2 red spots/cell containing spots).
The percentage of positive cells after a 30-min treatment with
cocaine was around 30 (with 2 red spots/cell containing spots)
(Figure 5B). Thus, cocaine pretreatment did not significantly
alter D1R-σ2R complex formation. When PLA was developed to
detect D2R and σ2R complexes, the results (19% with 1.3 red
spots/cell containing spots) were similar to those in the negative
control (20% with 1.4 red spots/ cell containing spots), i.e., no
evidence of heteroreceptor formation was obtained. Pretreatment
with cocaine did not lead to the appearance of heteromer
complexes formed by D2R and σ2R (Figure 5B). These results
agree with the BRET assays that did not find sign of interaction
between the D2R-Rluc and σ2R-YFP but between the D1R-Rluc
and σ2R-YFP pair.
To demonstrate the effect of cocaine over D1R-mediated
signaling in a more physiological environment, we analyzed
cAMP and MAP kinase signaling pathways in primary cultures
of striatal neurons. As striatal neurons express the two sigma
receptors, the siRNA approach was used to silence sigma
receptor expression. On the one hand, in neurons transfected
with siRNA for σ1R, and consequently expressing D1R and
σ2R, cocaine and PB-28 led to a decrease in agonist-induced
cAMP levels and to an enhancement in MAP kinase signaling
(Figures 5C,G). On the other hand, in neurons transfected
with the siRNA for σ2R, and consequently expressing D1R
and σ1R, cocaine but not PB-28 induced an increase in the
cAMP signal and a decrease in the ERK1/2 phosphorylation
signal (Figures 5D,H). Most of these results agree with those
obtained in the heterologous system. However, in striatal neurons
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FIGURE 5 | Expression and function of σ2R-D1R complexes in primary cultures of striatal neurons. In (A,B) PLA assay was developed in striatal primary cultures of
neurons pretreated or not with cocaine 30 µM for 30 min. σ2R-D1R or σ2R-D2R heteromer complexes were detected by the use of specific antibodies (1/100
dilution) against σ2R and D1R or σ2R and D2R. Confocal microscopy images (four superimposed sections) were obtained where nuclei were stained with Hoechst
(1/100). Scale bar 5 µm (A). Quantification of the PLA provides in the Y-axis the ratio r (number of red spots/cell containing spots) and, above each bar, the
percentage of positive cells versus the total number of cells (blue nucleus) (B). Data are the mean ± SEM of four different fields in five independent preparations. One
way ANOVA and Dunnett’s multiple comparison post hoc test showed statistically significant differences versus control (∗∗p < 0.01). Primary cultures of striatal
neurons, control (E,I) or transfected with siRNA for σ1R (C,G), σ2R (D,H) or both (F,J) were treated with 30 µM cocaine for 30 min or 300 nM PB-28 prior to 200 nM
SKF-81297 stimulation. cAMP levels (C–F) or MAP kinase activation l (G–J) were determined. Basal [cAMP] is considered 100%. The basal level of pERK1/2 is
considered 100%. Values are the mean ± SEM of 10–15 different experiments. One way ANOVA followed by a Dunnett’s multiple comparison post hoc test showed
a significant effect of treatments versus not treated cells (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001) and a significant effect of treatments versus SKF-81297 (#p < 0.05,
##p < 0.01, and ###p < 0.001).
expressing D1R and both sigma receptors, cocaine treatment led
to a net effect that showed predominance of σ1R- versus σ2R-
mediated modulation (Figures 5E,I). These findings could be
due to a higher expression of σ1R-D1R complexes versus σ2R-
D1R but they may also result from the lower affinity of the
cocaine/σ2R binding (Lever et al., 2016). Finally, another control
was performed to show that pretreatment with the σ2R selective
agonist, PB-28, or with cocaine, did not result in any signal
modulation in cells expressing D1R but silenced σ1R and σ2R
expression (Figures 5F,J).
D1R-Mediated Signaling Is Modulated by
σ1R in Acute and by σ2R in Chronic
Conditions
In situ PLAs were performed to identify D1R-σ1R and D1R-σ2R
heteroreceptor complexes in striatal sections from Sprague–
Dawley rats receiving cocaine under acute or chronic regimes
(see section “Materials and Methods”) (Figure 6A). When
striatal sections of vehicle-treated animals were analyzed, it
was observed that 38.5% of cells showed D1R-σ1R complexes
with 2.5 red spots/cell containing spots, while only 25% of
cells showed D1R-σ2R complexes with 2.1 dots/cell (Figure 6B).
When Sprague–Dawley rats were acutely treated with cocaine,
it was observed that both D1R-σ1R and D1R-σ2R complex
expression increased. However, the D1R-σ1R complexes doubled
its expression while D1R-σ2R complex expression suffered a slight
increase (respectively, 54% of cells showed red spots with 4.5
spots/cell and 33% with 2.3 spots/cell). Interestingly, in the case
of rats chronically treated with cocaine, the D1R-σ1R heteromer
complex expression was not affected (34% of cells showed red
spots with 2.4 spots/cell containing spots) compared to control
animals, while the D1R-σ2R heteromer expression significantly
increased (35% of cells containing spots with 3.4 spots/cell
containing spots) (Figure 6B). These results indicate that
acute cocaine treatment strongly increases D1R-σ1R complexes
formation in striatal rat sections but chronic cocaine treatment
only drives D1R-σ2R complex expression. Then, we questioned
if the cocaine-induced alterations in D1R-σ1R and D1R-σ2R
complex expression had signaling consequences. To do so,
we analyzed SKF-81297-induced cAMP production in primary
cultures of striatal neurons pretreated with vehicle or cocaine for
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FIGURE 6 | D1R-mediated signaling is modulated by σ1R in cocaine acute and by σ2R in cocaine chronic exposure. In (A,B) PLA assay was developed in brain
sections from male Sprague–Dawley rats i.p. injected with vehicle or 15 mg/kg cocaine under acute or chronic regimes (see section “Materials and Methods”).
D1R-σ1R or D1R-σ2R heteromer complexes were detected by PLA using of specific antibodies against D1R (1/100), σ1R (1/100, Santa Cruz Biotechnology, Dallas,
TX, United States) or σ2R (1/100). Confocal microscopy images (four superimposed sections) were obtained where nuclei were stained with Hoechst (1/100). Scale
bar 5 µm (A). Quantification of the PLA provides in the Y-axis the ratio r (number of red spots/cell containing spots) and, above each bar, the percentage of positive
cells versus the total number of cells (blue nucleus) (B). Data are the mean ± SEM of six different fields in five independent preparations. One way ANOVA and
Dunnett’s multiple comparison post hoc test showed statistically significant differences versus control (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001), significant differences
in D1R-σ1R complex amount between acute and chronic treatments (&&&p < 0.001) and significant differences in D1R-σ2R heteromer complex amount between
acute and chronic treatments ($$p < 0.01). cAMP determination experiments were developed in primary cultures of striatal neurons, control (C), transfected with
3 µg siRNA for σ1R (D) or 3 µg siRNA for σ2R (E). Cultures were divided into 9 groups and pretreated with vehicle or 30 µM cocaine for different time periods (from
0.5 h to 7 days) prior to receptor activation using 200 nM SKF-81297. Basal [cAMP] is considered 100%. Values are the mean ± SEM of five different experiments.
One way ANOVA followed by a Dunnett’s multiple comparison post hoc test showed a significant effect of treatments versus basal (∗p < 0.05, ∗∗∗p < 0.001) and a
significant effect of cocaine treatments (white bars) versus cocaine non-exposed neurons (black bar) (#p < 0.05, ##p < 0.01, and ###p < 0.001).
different times (from 0.5 h to 7 days). Interestingly, we observed
that at short times SKF-81297-induced cAMP levels were further
increased. In agreement with results in HEK-293 cells, cocaine
binding to the σ1R induced a positive modulation over dopamine
D1R-mediated signaling. When primary cultures of neurons
were longer exposed to cocaine (1–7 days), SKF-81297-induced
increase in cAMP levels was inhibited (Figure 6C). Taking into
account the results in HEK-293 cells such effect seems associated
to D1R-σ2R complex formation and to the ability of σ2R to
counteract the SKF-81297-induced increases of cAMP. To check
whether these interpretations were correct, i.e., if sigma receptors
were responsible of cocaine-induced modulations over D1R-
mediated signaling, primary striatal neurons were transfected
with siRNA specific for σ1R or σ2R. On the one hand, cocaine
pretreatment (0.5 h to 7 days) blocked SKF-81297-induced
accumulation of cAMP levels in primary cultures of neurons
transfected with siRNA for σ1R, i.e., expressing D1R and σ2R
(Figure 6D). On the other hand, 0.5 h and 2 h pretreatment
of cocaine potentiated the SKF-81297-induced increases in
cAMP levels in primary neurons transfected with siRNA for
σ2R, i.e., expressing D1R and σ1R. However, longer periods of
cocaine exposure (1–7 days) produced no effect (Figure 6E).
These results suggest that in acute cocaine treatment D1R form
heteromers mainly with σ1R, prevailing the D1R-σ1R-mediated
signaling. In contrast, in the chronic situation, the increase
of σ1R-D1 heteromer complex expression observed in acute
conditions disappear but the increase in the D1R-σ2R complex
expression is maintained, being the σ2R responsible of the
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cocaine modulation over D1R, hence prevailing the D1R-σ2R-
mediated signaling.
DISCUSSION
Sigma receptors are relevant in cocaine addiction, because
binding of cocaine to these receptors modulates dopaminergic
transmission. Although cocaine can bind to both σ1R and
σ2R, they are not closely related and no common structural
properties have been identified. With respect to the modulation
of receptor-mediated signaling, a relevant difference is revealed
by the formation of heteroreceptor complexes. On the one hand,
σ1R interacts with D1 and D2 dopamine receptors (Navarro
et al., 2010; Moreno et al., 2014). Interestingly, we here report
that σ2R may form heteromeric complexes with D1R but not
with D2R.
Information on PGRMC1/σ2R expression in brain is partial.
Intlekofer and Petersen (2011) confirmed data by Krebs et al.
(2000) showing enrichment of the receptor in nuclei of the
hypothalamus that are important for female reproduction.
Petersen et al. (2013) in 2013, reviewed neuroanatomical data
on the expression PGRMC1 and related proteins in CNS
neuroendocrine nuclei. To our knowledge, information on
expression in other neural regions is either absent or preliminary.
Interestingly, a recently developed fluorescent probe tested
in rat brain indicates that the receptor is more present in
neurons than in glial cells (Zeng et al., 2016). Despite good
in vitro properties, some of the radiolabeled probes that were
developed for in vivo σ2 receptor imaging have not reached
the final objective (Abate et al., 2013; Selivanova et al., 2015).
In contrast, recently reported 18F-labeled PET probes, with
enhanced brain uptake and σ2R selectivity (in mice), show
promise for in vivo imaging of the receptor in the human brain
(Wang et al., 2017). Surely these novel tools will be instrumental
to achieve a more detailed mapping of the receptor in the
CNS, specially in those areas in which dopamine receptors are
expressed. There is, however, strong evidence of expression in the
striatum; for instance, a recent report shows that receptor agonist
regulate dopaminergic input into the striatum and the receptor
is presynaptically expressed the nucleus accumbens (Klawonn
et al., 2017). Furthermore, pioneering studies by Werling and
colleagues showed σ2R involvement in control of dopamine
transporter activity in striatum (Derbez et al., 2002) and that the
striatal receptor was a target of cocaine (Nuwayhid and Werling,
2006).
The results presented here and those already reported
(Navarro et al., 2010, 2013) show that in equivalent experimental
configurations, cocaine binding to σ1R improves the
accumulation of cAMP mediated by D1R and inhibits MAP
kinase signaling. Cocaine, via σ2R, blocks D1-mediated cAMP
accumulation and enhances MAP kinase activation. Importantly,
similar results were obtained in HEK-293T cells and primary
neuronal cultures.
D1R can form complexes and high- order heteromers by
interacting simultaneously with the σ1 and σ2 receptors, σ1R
being able to displace σ2R, but not vice versa. Navarro et al. (2010)
reported an increase in the plasma membrane expression of σ1R
after acute exposure to cocaine. When increase in σ1R levels in
the plasma membrane occurs, σ2R is displaced from the D1R-σ2R
or D1R-σ2R-σ1R heteroreceptor complexes. Such phenomenon
results in increasing the amount of D1-σ1 heteroreceptors and
D1R signaling whereas, as reported by Navarro et al. (2013),
reducing D2R-mediated actions. However, in a longer exposure
to cocaine, the signaling mediated by the dopamine D1R fits
more with that occurring via a D1R-σ2R functional unit. These
data suggest that the initial cocaine-induced overexpression
in the plasma membrane of the σ1R is transient; once these
levels decrease, due to internalization or other still unknown
mechanisms, σ2 is the predominant receptor forming heteromers
with dopamine D1R.
Motor control in the basal ganglia is achieved through a
complex circuit composed of GABAergic neurons that contain
mainly D1R (direct pathway) and GABAergic neurons containing
mostly D2R (indirect pathway) (Grillner and Robertson, 2016).
Fine motor control is achieved by a balance of dopaminergic
signals, one via D1 receptors, which are Gs coupled, and another
via D2 receptors, which are Gi coupled (Jenner, 1995; Gerfen,
2000). The deterioration of motor control by cocaine depends on
the imbalance of the direct/indirect pathway, but the underlying
mechanism remains unclear. Although the scenario is complex,
cocaine is known to increase cAMP levels in cells expressing
D1R-σ1R (Navarro et al., 2010). Therefore, cocaine seems
to be increasing in the direct pathway the cAMP-dependent
dopaminergic output, namely activation of protein kinase A
and cAMP-regulated DARPP-32 phosphoprotein (Svenningsson
et al., 2004). Through the same receptor (σ1R), cocaine leads to
a deterioration of the dopaminergic performance of the indirect
route (Navarro et al., 2013). In addition to the imbalance resulting
from these σ1R-dependent effects, our results demonstrate that
trimers of D1, σ1, and σ2 receptors may be formed and
that cocaine acting on these heteromers reduces the negative
modulation exerted by the D1R-σ1R complexes.
The results here presented also show that the MAP kinase
signaling pathway is particularly affected by the action of
cocaine upon dopamine-sigma heteroreceptors. While in cells
expressing the D1R-σ1R heteromer, cocaine decreased ERK1/2
phosphorylation, cocaine did the opposite in cells expressing
the D1R-σ2R heteromer. It is known that ERKs are involved
in the plastic changes induced by the consumption of drugs
of abuse (Radwanska et al., 2005). In addition, the inhibition
of ERK phosphorylation alters learned place-preference in a
paradigm of drug-of-abuse consumption, whereas activation of
ERK1/2 is necessary to establish the association between place
preference and drug consumption (Valjent et al., 2006; Du
et al., 2017). In this context, knocking down ERK1 has shown
that enhanced ERK2 signaling and repeated exposure to the
drug facilitate the plastic changes leading to drug addiction
(Ferguson et al., 2006). It should be noted that the temporal
pattern of MAP kinase activation in the mouse brain is differently
induced by addictive or non-addictive drugs (Valjent et al., 2004).
Interestingly, Zhang et al. (2017) have described that D1
receptor antagonists alter in cocaine-treated mice the length of
nucleus accumbens postsynaptic densities, i.e., cocaine-induced
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long-term plasticity; however, the mechanism underlying this
phenomenon has not been described. According to the previous
reports and to our results, it may be suggested that potentiation of
MAP kinase pathway mediated by the D1R-σ2R heteromer may
be the mechanism by which the σ2R would induce long term
neuronal plasticity. The predominant role of the σ1R in acute
cocaine use shifts to a more relevant role of σ2R in the chronic
condition leading to the establishment of addiction. In any case,
the relative expression of the two receptors in a given neuron
seems important in determining the fate of the cell when the drug
of abuse is consumed.
In acute cocaine exposure, σ1R modulation of D1R-mediated
signaling prevails, but in longer exposures, there is a shift to
regulation by σ2R. Recently, Singer et al. (2017) have determined
that neuronal plasticity initiate 2 h after cocaine exposure. The
mechanism of action described in this paper cannot explain some
of the results reported by Matsumoto et al. (2007) and Lever et al.
(2014) who report that σ2R receptor antagonists block the effects
of cocaine-induced hyperlocomotion. It should be, however,
noted that a recent report show benefits of a σ2R -selective
agonist, siramesine, for decreasing cocaine effects via reduction of
dopaminergic and glutamatergic input to the striatum (Klawonn
et al., 2017). On the one hand, it is a reasonable assumption that
σ1R is more involved in the regulation of D1R signaling at acute
exposure. However, it remains to be determined whether some
of the results reported on the impact of cocaine on locomotion
are due to the use of non-selective ligands, that is, ligands
that can bind to both sigma receptors and alter their function.
Alternatively, it may happen that σ2R is also affecting the direct
route in acute conditions. What our results undoubtedly indicate
is that σ2R becomes the main player in conditions of chronic
exposure to the drug. In summary, some of the addictive and
motor actions of cocaine are the result of a balance between
cocaine-σ1R versus cocaine-σ2R impact on activation of D1R and
D2R (and D1R-D2R, see Perreault et al., 2016) in ad hoc CNS
circuits.
MATERIALS AND METHODS
Reagents
Cocaine-chlorhydrate was provided by the Spanish
Agencia del Medicamento (Ref. n◦: 2003C00220). σ2R
agonist, 1-Cyclohexyl-4-[3-(1,2,3,4-tetrahydro-5-methoxy-
1-naphthalenyl)propyl]piperazine dihydrochloride (PB-28),
D1R agonist (±)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-
1H-3-benzazepine hydrobromide (SKF-81297) and D2R
agonist, sumanirole, were purchased from Tocris, Bristol,
United Kingdom.
Fusion Proteins and Expression Vectors
cDNAs for human versions of D1R, D2R, σ1R, or σ2R cloned
into pcDNA3.1, were amplified without their stop codons using
sense and antisense primers harboring: EcoRI and KpnI sites
to subclone D1R, D2R, σ1R, and σ2R in pcDNA3.1Rluc vector
(pRluc-N1, PerkinElmer Life and Analytical Sciences, Wellesley,
MA, United States) or HindIII and BamHI sites to clone D1R,
D2R, σ1R, and σ2R in pEYFP-N1 vector (enhanced yellow
variant of GFP; Clontech), or EcoRI and BamHI sites to clone
σ2R in a cherry-containing vector (pcDNA3.1Cherry). Amplified
fragments were subcloned to be in-frame with restriction sites
for pRluc-N1, pEYFP-N1, or pcDNA3.1Cherry vectors to provide
plasmids that express proteins fused to Renilla Luciferase (D1R-
Rluc, D2R-Rluc, σ1R-Rluc, and σ2R-Rluc), YFP (D1R-YFP, D2R-
YFP, σ1R-YFP, and σ2R-YFP) or cherry (σ2R-Cherry) at the
C-terminal end.
Cell Lines and Transient Transfection
HEK-293T human embryonic kidney cells were grown at 37◦C in
a humid atmosphere with 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco, Thermo Fischer Scientific, Madrid,
Spain) supplemented with 2 mM L-glutamine, 100 µl/ml
sodium pyruvate, 100 U/ml penicillin/streptomycin, MEM
Non-Essential Amino Acid Solution (1/100) and 5% (v/v) heat
inactivated foetal bovine serum (FBS) (all supplements were
from Invitrogen, Paisley, Scotland, United Kingdom). Cells were
transiently transfected with constructs encoding for receptors,
fusion proteins, and/or siRNAs by the polyethylenimine
(PEI; Sigma–Aldrich, St. Louis, MO, United States) method.
Transfected cells were incubated in serum-free medium that
after 4 h was replaced by complete medium. Experiments were
carried out 48 h later.
Neuronal Primary Cultures
Primary cultures of striatal neurons were obtained from 19-day
embryos of Sprague–Dawley rats. Cells were isolated as described
in Hradsky et al. (2013) and plated at a confluence of 40,000
cells/0.32 cm2. Cells were maintained for 12 days in Neurobasal
medium supplemented with 2 mM L-glutamine, 100 U/ml
penicillin/streptomycin, and 2% (v/v) B27 supplement (Gibco) in
6-well plates. When indicated, cells were transiently transfected
with the corresponding siRNA (3 µg plasmid siRNA per well)
using the LipofectamineTM 2000 (Invitrogen, Life Technologies,
Darmstadt, Germany). Transfected cells were incubated in
serum-free medium that after 4 h was replaced by complete
medium. Experiments were carried out 48 h later.
Cocaine Treatment of Sprague–Dawley
Rats
Male Sprague–Dawley rats weighing 200–220 g were selected
for the experiments. Rats were kept in controlled environment
with 12 h light-dark cycle at 21◦C room temperature. Food
and water were provided ad libitum. Experimental procedures
were approved by the Bioethical Committee of the Faculty of
Biological Sciences of the Pontificia Universidad Católica de
Chile and follow the international guidelines (NIH Guide for
the Care and Use of Laboratory Animals). Rats were housed
and handled in colony for three days, and then were divided
in two experimental groups: acute and chronic, with respective
saline controls. Chronic cocaine administration consisted in two
injections of cocaine (15 mg/kg, i.p.) per day for 14 days at
11:00 A.M. and 5:00 P.M., as described by Liu et al. (2005).
Acute cocaine administration consisted of two injections of
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cocaine (15 mg/kg, i.p.) for only one day. The same protocol
of administration was used in control animals receiving saline
injections. Rats were sacrificed 17 h. after the last saline or cocaine
injection following the protocol of Liu et al. (2005). Cocaine HCl
was donated by the National Institute on Drug Abuse (NIDA,
United States).
Immunocytochemistry
HEK-293T cells were treated with 30 µM cocaine or vehicle
for 30 min, then were washed with PBS, fixed in 4%
paraformaldehyde for 15 min and washed with PBS containing
20 mM glycine to quench free aldehyde groups. After
permeabilization with PBS-glycine buffer containing 0.2% Triton
X-100 for 5 min, cells were blocked with PBS containing 1%
bovine serum albumin (BSA) for 1 h at room temperature.
D1R-YFP and D2R-YFP were detected by its own fluorescence
(wavelength 530 nm), and σ2R-Rluc was stained using a primary
anti-Rluc mouse monoclonal antibody (1/200, Millipore, CA,
United States) for 1 h, washed and stained for another hour
with the secondary Cy3-conjugated donkey anti-mouse antibody
(1/200, Jackson Immunoresearch Laboratories, West Grove,
PA, United States). Nuclei were stained with Hoechst (1/100,
Sigma–Aldrich, St. Louis, MO, United States) and then samples
were rinsed several times and mounted with Mowiol 30%
(Calbiochem). Images were taken using a Leica SP2 confocal
microscope (Leica Microsystems, Mannheim, Germany).
Proximity Ligation Assay
For PLAs, HEK-293T cells or primary cultures of striatal neurons
were grown on glass coverslips while cocaine-administered rat
sections were mounted and dried directly on glass coverslips.
Samples were treated with 30 µM cocaine or vehicle for 30 min,
then were washed with PBS and fixed in 4% paraformaldehyde
for 15 min, washed with PBS containing 20 mM glycine,
permeabilized with the same buffer containing 0.05% Triton
X-100 for 5 min, and washed with PBS. Then, samples were
incubated at 37◦C with the blocking solution for 1 h. Heteromers
were detected using the Duolink in situ PLA detection kit
(OLink Bioscience, Bioscience, Uppsala, Sweden) following the
instructions of the supplier. To detect D1R-σ2R or D2R-σ2R
heteromers, cells and primary cultures were incubated overnight
with anti D1R (1/100), anti σ2R (1/100) and Hoechst (1/100),
or anti D2R (1/100), anti σ2R and Hoechst. Samples were
processed using PLA probes that bind to the primary antibodies
(Duolink II PLA probe anti-mouse plus and Duolink II PLA
probe anti-goat minus). Images were taken using a Leica SP2
confocal microscope (Leica Microsystems, Mannheim, Germany)
equipped with an apochromatic 63× oil-immersion objective
(numerical aperture 1.4) and 405 and 561 nm laser lines. For
each field of view a stack of two channels (one per staining)
and 4–6 Z stacks with a step size of 1 µm were acquired.
Quantification of the number of cells containing one or more
red spots versus total cells (blue nuclei) and, in cells containing
spots, of the number of red spots/cell ratio, was conducted
using dedicated software known as Duolink ImageTool (ref:
DUO90806, Sigma-Olink). This software has been developed
for quantification of PLA signals and cell nuclei in images
generated from fluorescence microscopy. One-way ANOVA
followed by Dunnett’s post hoc multiple comparison test was used
for statistical analysis.
Resonance Energy Transfer
For bioluminescence resonance energy transfer (BRET), HEK-
293T cells were transiently cotransfected with a constant
amount of cDNA encoding for proteins fused to Rluc and
increasing amounts of cDNAs corresponding to proteins fused
to YFP (see figure legends). To normalize the number of
cells, protein concentration was determined using a Bradford
assay kit (Bio-Rad, Munich, Germany) using BSA dilutions as
standards. To quantify protein YFP expression, cells (20 µg
of protein) were distributed in 96-well plates (black plates
with a transparent bottom), and fluorescence was read in
the FluoStar Optima Fluorimeter (BMG Labtech, Offenburg,
Germany) equipped with a high-energy xenon flash lamp,
using a 10-nm bandwidth excitation filter at 400 nm reading.
Protein fluorescence expression was determined as fluorescence
of the sample minus the fluorescence of cells expressing the
BRET donor alone. For BRET measurements, the equivalent
of 20 µg of cell suspension was distributed in 96-well plates
(Corning 3600, white plates; Sigma), and coelenterazine H
(5 µM; Invitrogen) was added. After 1 min, readings were
obtained using a Mithras LB 940 (Berthold Technologies), which
allows the integration of the signals detected in the short-
wavelength filter at 485 nm and the long-wavelength filter
at 530 nm. To quantify protein-Rluc luminescence, readings
were also performed 10 min after addition of coelenterazine
H. For SRET assays, cells were transiently cotransfected with
constant amounts of cDNA encoding for both receptor fused
to Rluc and YFP proteins, and with increasing amounts of
cDNA corresponding to the receptor fused to cherry protein.
After 48 h of transfection, quantification was performed in
parallel in aliquots of transfected cells (20 µg of protein):
quantification of receptor YFP or receptor Rluc expression was
performed as indicated for BRET experiments. Quantification
of receptor-Cherry expression, cells were distributed in 96-well
plates (Corning black plates with a transparent bottom), and
fluorescence was read in the FluoStar Optima Fluorimeter using
a 10 nm bandwidth excitation filter at 590 nm reading. For SRET
quantification, cells were distributed in 96-well plates (black
plates with transparent bottom), and coelenterazine H (5 µM)
was added. After 1 min, the readings were collected using a
FluoStar Optima Fluorimeter, which allows the integration of
the signals detected in the short-wavelength filter at 530 nm and
the long-wavelength filter at 590 nm. Net BRET and net SRET
were defined as [(long-wavelength emission)/(short-wavelength
emission)] – Cf, where Cf corresponds to [(long-wavelength
emission)/(short-wavelength emission)] for the Rluc construct
expressed alone in the same experiment. Both fluorescence
and luminescence were measured before every experiment to
confirm similar donor expressions (∼100,000 bioluminescence
units) while monitoring the increase in acceptor expression
(1,000–40,000 fluorescence units). BRET or SRET was expressed
as, respectively, milliBRET (mBU) or milliSRET (mSU) units
(net BRET or SRET × 1,000). Data were fitted to a nonlinear
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regression equation, assuming a single-phase saturation curve
with GraphPad Prism software (GraphPad Software). The relative
amount of BRET or SRET is given as a function of 100× the ratio
between the fluorescence of the acceptor (YFP or cherry) and the
luciferase activity of the donor (Rluc).
cAMP Determination
cAMP levels were assayed with different forskolin concentrations
and cell densities to select the most appropriate conditions
of the assay, which were 0.5 µM forskolin and 5,000 HEK-
293T cells or 7,500 neurons. Transfected HEK-293T cells or
neurons were incubated in serum-free medium for 3 h before
the experiment. Then, cells were placed in 384-well microplates
in medium containing 50 µM zardaverine (Tocris Bioscience).
Cells were then preincubated with vehicle, the σ2R agonist,
PB-28 (300 nM) or cocaine (30 µM) for 15 min, followed
by dopaminergic stimulation with the D1R agonist, SKF-81297
(200 nM), the D2R agonist, sumanirole (500 nM) or vehicle.
After another incubation period of 15 min, 0.5 µM forskolin
or vehicle were added. Readings were performed 15 min later
by the use of a homogeneous time-resolved fluorescence energy
transfer (HTRF) method requiring the Lance Ultra cAMP kit
(PerkinElmer) and fluorescence readings (at 635 nm) in a
PHERAstar Flagship microplate equipped with a time-resolved
fluorescence optical module (BMG Labtech).
ERK1/2 Phosphorylation
To determine ERK1/2 phosphorylation, 40,000 HEK-293T
cells/well or 50,000 neurons/well were plated in transparent
Deltalab 96-well plates and kept in the incubator for 48 h.
The medium was substituted by serum-free DMEM medium for
2–4 h before initiating the experiment. Then, HEK-293T cells and
striatal neurons were pretreated for 10 min at 25◦C with vehicle,
PB-28 (300 nM) or cocaine (30 µM) followed by the addition
of 200 nM SKF-81297, the D1R specific agonist. 10 min after
activation, cells/neurons were placed on ice and washed twice
with cold PBS before the addition of 30 µl of lysis buffer for
15 min. Supernatants (10µl) were placed in white ProxiPlate 384-
well microplates, and ERK1/2 phosphorylation was determined
using the AlphaScreen R©SureFire R© kit (Perkin Elmer) and the
EnSpire R© Multimode Plate Reader (PerkinElmer, Waltham, MA,
United States).
Label-Free Dynamic Mass Redistribution
Assays (DMR)
HEK-293T cells and neuronal primary cultures were seeded
in 384-well sensor microplates for 24 h before the assay
to obtain 70–80% confluent monolayers constituted by 5,000
HEK-293T cells or 14,000 neurons per well. Previous to the
assay, cells were washed twice with assay buffer (HBSS with
20 mM HEPES and 0.1% DMSO, pH 7.15) and incubated
for 2 h in 40 µl/well of assay-buffer in the reader at 24◦C.
Hereafter, the sensor plate was scanned and a baseline optical
signature was recorded before adding (10 µl) vehicle, cocaine
(30 µM) or PB-28 (300 nM) for 30 min followed by SKF-
81297 (200 nM) addition. All compounds dissolved in assay
buffer. Then, DMR responses were monitored for at least 3,600 s
using an EnSpire R© Multimode Plate Reader (PerkinElmer Life
and Analytical Sciences, Waltham, MA, United States). Sensitive
measurements of changes in local optical density mimicking
cellular mass movements induced upon receptor activation were
detected using EnSpire Workstation Software v4.10, and curves
were normalized with respect to the baseline.
Data Analysis
The data in graphs are the mean± SEM. The test of Kolmogorov–
Smirnov with the correction of Lilliefors was used to evaluate
normal distribution and the test of Levene to evaluate the
homogeneity of variance. Parametric statistic methods were used,
because results in the different groups showed normality and
homogeneity of variance. Significance was analyzed by one-way
ANOVA, followed by Dunnett’s multiple comparison post hoc
test. GraphPad Prism software version 5 was used for the
statistical analysis. Significant differences were considered when
p< 0.05.
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